Health Encyclopedia

Juvenile rheumatoid arthritis

Definition

Juvenile rheumatoid arthritis (JRA) is a general term for the most common types of arthritis in children. It is a long-term (chronic) disease resulting in joint pain and inflammation, which may lead to joint damage.

Alternative Names

Juvenile chronic polyarthritis; JRA; Still's disease; Juvenile idiopathic arthritis

Causes, incidence, and risk factors

JRA occurs in 50-100 per 100,000 children in the United States. It usually occurs before age 16.

JRA is divided into several categories:

Systemic JRA occurs in about 10% of cases. It involves joint pain, swelling, fevers, and rash. It is similar to adult Still's disease. The cause of this form of JRA is unknown.
Polyarticular JRA occurs in about 40% of cases and involves multiple painful, swollen joints. The cause of this form of JRA is also unknown. Some children may have a positive rheumatoid factor and the condition may turn into rheumatoid arthritis.
Pauciarticular JRA occurs in about 50% of cases and involves only a few joints. Some of these children, in particular boys, will be HLA-B27 positive. HLA-B27 is a substance called a gene marker that is associated with several autoimmune disorders.

Symptoms

Arthritis symptoms:

Joint stiffness on arising in the morning
Limited range of motion
Slow rate of growth or uneven arm or leg growth
Hot, swollen, painful joints
A child may stop using an affected limb
Back pain

Systemic JRA symptoms:

Fever, usually high fevers every day
Rash that comes and goes with the fever
Swollen lymph nodes (glands)

JRA can also cause eye inflammation. These symptoms include:

Red eyes
Eye pain
Photophobia (increased pain when looking at a light)
Visual changes

Signs and tests

The physical examination shows swollen, warm, and tender joints that hurt to move. The child may have a rash. Other signs include an enlarged liver, enlarged spleen, or swollen lymph nodes.

Blood tests may include:

CBC
ESR (sedimentation rate)
ANA
RA factor
HLA antigens for HLA B27

The doctor may need to tap a joint. This means that they will put a small needle into a joint that is swollen. This can help to find the cause of the arthritis. By removing fluid, the joint may feel better, too. Sometimes, the doctor will inject steroids into the joint to help decrease the swelling.

Other tests:

X-ray of a joint
X-ray of the chest
ECG
Eye exam by an ophthalmologist

Treatment

Medicines used to treat this condition may include:

Nonsteroidal anti-inflammatory drugs (NSAIDs)
Corticosteroids
An antimalaria medicine called hydroxychloroquine, which helps reduce inflammation related to JRA
Disease-modifying anti-rheumatic drugs (DMARDs), including methotrexate
Biologic drugs, such as such as etanercept and infliximab, which block high levels of inflammatory proteins

Note: Talk to your health care provider before giving aspirin or NSAIDs to children.

Physical therapy and exercise programs may be recommended. Surgery may be needed in some cases, including joint replacement.

Expectations (prognosis)

JRA is seldom life threatening. Long periods of spontaneous remission are typical. Often, JRA improves or goes into remission at puberty. Approximately 75% of JRA patients eventually enter remission with minimal functional loss and deformity.

For additional information and resources, see arthritis support group.

Complications

Total joint destruction of the major weight-bearing joints
Loss of vision or decreased vision
Chronic spondyloarthropathy (back stiffness)

Calling your health care provider

Call for an appointment with your health care provider if you notice symptoms of juvenile rheumatoid arthritis. Also call your health care provider if your symptoms get worse, do not improve with treatment, or if new symptoms develop.

Prevention

There is no known prevention for JRA.

Review Date:5/27/2007
Reviewed By:Steve Lee, DO, Rheumatology Fellow, Loma Linda University Medical Center, Loma Linda, CA. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.